Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

OBJECTIVE: To assess 4 adverse renal outcomes in a heterogeneous cohort of patients with systolic heart failure (HF) who were prescribed sacubitril-valsartan vs angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB). PATIENTS AND METHODS: The OptumLabs Database Warehouse, wh...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mayo Clin Proc Innov Qual Outcomes
Auteurs principaux: Tan, Nicholas Y., Deng, Yihong, Yao, Xiaoxi, Sangaralingham, Lindsey R., Shah, Nilay D., Rule, Andrew D., Burnett, John C., Dunlay, Shannon M., Sangaralingham, S. Jeson
Format: Artigo
Langue:Inglês
Publié: Elsevier 2021
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105557/
https://ncbi.nlm.nih.gov/pubmed/33997628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.10.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires